New Horizons for Multiple Sclerosis Therapy: 2025 and Beyond
The advances achieved against multiple sclerosis (MS) represent one of the great success stories of modern molecular medicine. The development of therapies with increasing selectivity and safety, guided by gains in understanding the fundamental immunology, neurobiology, genetics, and triggers of this disease, have broadened the traditional focus on ...
Joseph J. Sabatino Jr.+2 more
wiley +1 more source
The Metabolic Syndrome among Postmenopausal Women in Gorgan [PDF]
In this study, we aimed to assess levels of serum 25-hydroxyvitamin D in relation to metabolic syndrome among postmenopausal women in Gorgan. The study group included 100 postmenopausal women who were referred to the different Health Centers in Gorgan ...
Marjani, A., Moghasemi, S.
core +3 more sources
Expert Perspective: How, When, and Why to Potentially Stop Antiresorptive Drugs in Osteoporosis
Osteoporosis is a chronic disease, and antiresorptive treatments are often continued for many years. Despite their established efficacy in reducing fracture risk, the most commonly used antiresorptive treatments, bisphosphonates and denosumab, have short‐ and long‐term risks that, coupled with their benefits and other unique characteristics, influence ...
Giovanni Adami, Kenneth G. Saag
wiley +1 more source
Wage Work for Women: The Menstrual Cycle and the Power of Water [PDF]
We hypothesise that women's participation in wage (off-farm) work is reduced when their greater water needs due to the menstrual cycle are not met because their household has poor access to water. For testing, we use the data from rural villages in China.
Maimaiti, Yasheng, Siebert, W. Stanley
core
Aims The incidence of postmenopausal bleeding (PMB) has been increasing over the past years. Little is known about the risk of PMB after COVID‐19 vaccination. Our study aimed to investigate this based on routine general practitioner (GP) healthcare data from the Netherlands.
Rana Jajou+5 more
wiley +1 more source
Women, work and the menopause: releasing the potential of older professional women [PDF]
Explores the experiences of menopause for professional women as part of a broader appreciation of health and well-being in later life. Executive summary This report presents the key findings and recommendations of a research project entitled Women,
Emily Bariola+5 more
core
The microfluidic Cervix Chip is an in vitro model of the human cervix lined by cervical epithelium interfaced with stromal cells cultured under dynamic flow that represents a new preclinical platform for studying mucosal immunity, host‐microbiome interactions, infections, fertility, and pregnancy health.
Zohreh Izadifar+4 more
wiley +1 more source
Age at menopause and its association with comorbidities in older women
Background — Menopause age is a potential mediator of subsequent mortality, morbidity, and quality of life after menopause. Objective — Since limited studies have reported an association between age at menopause and chronic diseases in the elderly ...
Ali Bijani+3 more
doaj +1 more source
Background Early onset of menopause is a risk factor for several health problems. The objective was primarily to investigate the association between early menopause and current, past active and passive smoking.
Sundby Johanne+3 more
doaj +1 more source
HUBUNGAN KARAKTERISTIK DEMOGRAFI DAN UMUR SAAT MENOPAUSE DENGAN KELUHAN SAAT MENOPAUSE (Studi pada wanita anggota posyandu usia lanjut di Kelurahan Putussibau Kota Kecamatan Putussibau Kabupaten Kapuas Hulu Kalimantan Barat tahun 2007) CORRELATION BETWEEN DEMOGRAPHY CHARACTERISTIC AND AGE IN MENOPAUSE WITH MENOPAUSE SYMPTOMS (Studies to women at adult "Posyandu" on Putussibau Village,Putussibau Subdistrict, Kapuas Hulu Regency, West Kalimantan 2007) [PDF]
Wanita usia 45 tahun keatas memasuki mas menopause dengan keluhan-keluhan yang diakibatkan defisiensi estrogen. Berkurangnya hormon estrogen akan mengalami beberapa kelainan, baik yang terjadi jangka pendek maupun jangka panjang.
DESI, DESI
core